Scottish Hospital Pharmacist’s Vocational Training Scheme



NES/ASAP Pharmacy Vocational Training Scheme

Specialist module

Infection and Antimicrobial Stewardship

VT3

Resources 16th March 2016 v 1.9

Under review

Please note that, with the exception of text books, the majority of resources within these lists will be available free of charge. Those which require either free registration or require a fee to be paid are annotated accordingly.

It is assumed that all participants will have registered with The Knowledge Network (TKN) and will have an Athens Password. Some of the URL links for such resources will link you direct to the article once you have entered your Athens password - if this fails, you should be able to access the article yourself via TKN.

Articles from the Journal of Antimicrobial Chemotherapy are available on the BSAC website or via TKN

There are a few resources listed which are on the YouTube platform and may not be accessible from NHS premises. These may require to be viewed from home or on a personal electronic device.

For webinars and videos the approximate running time is given in brackets after the name of the presentation

We would welcome your feedback - please contact NES Pharmacy if you have any comments about these resources or if you have trouble accessing any of the key resources.

|Contents |Page number |

|Bibliography |5 |

|Suggested texts - to be used for background knowledge as available locally for appropriate elements | |

| Element 1 Introduction to Antimicrobial Stewardship Core resources |7 |

|Element 2 Essential microbiology, resistance and basic immune function |11 |

|Element 3 Antimicrobial agents by therapeutic class |15 |

|Element 4 Healthcare Acquired Infection (HAI) |17 |

|Element 5 Sepsis Diagnosis and Management |21 |

|Element 6 Acute respiratory tract infection incorporating pneumonia and COPD |23 |

|Element 7 - Urinary tract infection (UTI) |26 |

|Element 8 Skin and soft tissue infection (SSTI) |29 |

|Element 9 Surgical infection & prophylaxis |33 |

|Element 10 Pharmacokinetics (PK) pharmacodynamics (PD) and therapeutic drug monitoring (TDM) |35 |

|Element 11 Data analysis and presentation Incorporating interpretation of audit data |39 |

|Element 12 Meningitis and CNS Infection |41 |

|Element 13 Endocarditis and Cardiovascular Infection |44 |

|Element 14 Bone & Joint Infections |46 |

|Element 15 Gastrointestinal (GI) infections |48 |

|Element 16 - Antibiotics used in pregnancy, neonates and paediatrics |51 |

|Element 17 Sexually transmitted infection (STI), human immunodeficiency virus (HIV) & other blood borne virus |56 |

|(BBV) | |

|Element 18 Tropical infectious diseases |62 |

|Element 19 Chronic respiratory tract infections - tuberculosis (TB), cystic fibrosis (CF) and non-CF |65 |

|bronchiectasis | |

|Element 20 Fungal infections |68 |

|Element 21 Outpatient parenteral antimicrobial therapy (OPAT) |70 |

Bibliography

|Suggested texts - to be used for background knowledge as available locally for appropriate elements | |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource|

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

|Resource ID |Name of resource |

Resource ID |Name of resource |Resource owner |Presenter

/Author |URL link direct to resource |Date Resource Accessed/ Comments | | |GENERAL OPAT REFERENCES | | | | | |142 |Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy |Clin Infect Dis ; 2004 ; 38 : 1651 -1672 |Tice AD et al | Parenteral Anti-Infective Therapy (OPAT) | | |444 |What are the ideal OPAT agents? (20 mins) |BSAC |DR Robin Howe | | | | | | | | | | | |SPECIFIC CONDITIONS OR DRUGS IN OPAT REFERENCES | | | | | |445 |Cystic Fibrosis & OPAT - What can we learn? |BSAC |Iara-Mina Sequeios | | | |505 |Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis |J Antimicrob Chemother (2013) 68 (7): 1650-1654. |Duncan CJA et al | | | |

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download